1 / 7

Histocompatibility Laboratory Bylaws and Policies Guidance Document

Histocompatibility Laboratory Bylaws and Policies Guidance Document. Histocompatibility Committee. What problem will the proposal solve?. Some policy and bylaw sections are better suited as guidance Some current histocompatibility bylaws and policies are vague.

dalek
Download Presentation

Histocompatibility Laboratory Bylaws and Policies Guidance Document

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Histocompatibility Laboratory Bylaws and Policies Guidance Document Histocompatibility Committee

  2. What problem will the proposal solve? • Somepolicy and bylaw sections arebetter suited as guidance • Some current histocompatibility bylaws and policies are vague

  3. What are the proposed solutions? • Create guidance document as a tool for laboratories to provide clarity on OPTN policy and bylaws requirements • Provide a template for best practices

  4. Content included in guidance • C.2 Facilities and Resources • C.2.C: Written Agreements • C.2.C #8: A process to obtain sensitization history for each patient • C.2.C #9: The frequency of periodic sample collection • C.2.C #11: The criteria for crossmatching • C.2.C #12: The assay format that will be used for antibody screening and for crossmatching • 4.4 Resolving Discrepant Donor and Recipient HLA Typing Results • 4.6 Crossmatching • 4.6.A Crossmatching for Kidney Transplants • Physical Crossmatching • Virtual Crossmatching • 4.7 Blood Type Determination • 4.8 Preservation of Excess Specimens

  5. How will members implement this proposal? • Member obligations won’t change (guidance not a policy change) • Guidance document posted on OPTN website

  6. How will the OPTN implement this proposal? • Anticipated Board approval: June 2017 • Will post guidance document on OPTN website • No programming required • No instructional effort currently needed

  7. Questions? Robert A. Bray, Ph.D., D(ABHI), HCLD/CC(ABB) Committee Chair rbray@emory.edu Alison Wilhelm Committee Liaison alison.wilhelm@unos.org

More Related